Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 971 - National Vaccine Advisory Committee - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Vaccine Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number971
Original Establishment Date11/14/1986Committee StatusChartered
Actual Termination Date Committee URLhttp://www.hhs.gov/nvpo/nvac
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*unlimited
Current Charter Date7/30/2019Designated Fed Officer Position Title*Communications Officer
Date Of Renewal Charter7/30/2021Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Ann
Exempt From Renewal*NoDesignated Federal Officer Middle NameL.
Specific Termination Authority42 U.S.C. 300aa-5Designated Federal Officer Last Name*Aikin
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixM.A.
Specific Establishment Authority*42 U.S.C. 300aa-5Designated Federal Officer Phone*(202) 690-5566
Effective Date Of Authority*11/14/1986Designated Federal Officer Fax*(202) 690-4631
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*ann.aikin@hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*National Policy Issue Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The National Vaccine Advisory Committee (NVAC) was established in 1987 to comply with Title XXI of the Public Health Service Act (P.L. 99-660) (Section 2105) (42 U.S. Code 300aa-5.). The NVAC serves an advisory role, providing peer review, consultation, advice, and recommendations to the Assistant Secretary for Health in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States; recommends research priorities and other measures to enhance the safety and efficacy of vaccines; and discusses evidence-based strategies for preventing vaccine preventable diseases across all age groups through the use of vaccines. The committee also advises the Assistant Secretary for Health in the implementation of the National Vaccine Plan. The committee meets three times per year in a two-day, public, in-person meeting that is also available as a webcast to those unable to attend in person. Notes from each meeting are transmitted to the Assistant Secretary for Health and posted to the NVAC website at https://www.hhs.gov/vaccines/nvac/index.html. The committee develops reports with recommendations on topics charged by the Assistant Secretary for Health. These reports are available on the HHS website at https://www.hhs.gov/vaccines/nvac/reports-and-recommendations/index.html. The reports and other recommendations voiced in meetings are transmitted to the Assistant Secretary for Health as well.
How is membership balanced?*The committee consists of 17 voting members. The membership is composed of 15 public members, including the chair, and 2 members who are designated to serve as official representatives of the vaccine manufacturing industry. The public members, who are selected from individuals engaged in various aspects of the vaccine enterprise, include (but are not limited to) physicians, members of organizations concerned with immunization and representatives of state and local health departments or public health organizations. The committee membership also consists of non-voting representatives from appropriate federal agencies and non-federal entities, including state and local health agencies or public health organizations that are engaged in and/or have interest in vaccine research, the manufacture of vaccines, and immunizations. Individuals who are appointed to represent federal organizations will serve as ex-officio members. Individuals who are appointed to represent non-federal entities will serve as non-voting liaison representatives. To ensure that the committee membership is fairly balanced in terms of the points of view presented, consideration is given to a broad representation of geographic areas, gender, race, ethnicity, and disability, as well as a broad representation of expertise.
How frequent & relevant are cmte mtgs?*The committee meets at a minimum three times a year. The committee deliberates and works to close gaps in immunization coverage areas that will have a substantial impact on public health policy and the prevention of infectious diseases and their complications through vaccination, by recommending actions to be taken -- by federal agencies and non-federal stakeholders -- that are involved in vaccine and immunization-related activities. Specifically, the committee offers advice and guidance on how to address existing barriers in the immunization delivery system, including strengthening immunization infrastructure, supporting providers and other partners who provide immunization services, increasing demand for immunization, and fostering vaccine development and innovation in new immunization technologies.
Why advice can't be obtained elsewhere?*NVAC’s mission, laid out in its charter, is very broad. NVAC is charged with advising the Assistant Secretary for Health on the entire range of vaccine and immunization policy which requires a depth of specialized expertise such as disease burden, public trust, vaccine access, and other issues affect the immunization system. Through focused and timely input, the committee plays an essential role in providing policy, research, and practice recommendations on pressing immunization issues, such as vaccine confidence, immunization disparities, disease outbreaks, and vaccine safety. NVAC is the only federal advisory committee that considers and makes recommendations across the entire U.S. immunization system, making their work vital to improving the lagging rates of adult immunization, addressing vaccine-specific disparities, and ensuring that we continue to immunize at rates high enough to maintain herd immunity and prevent the transmission of vaccine-preventable infectious disease.
Why close or partially close meetings?Full committee meetings are open to the public.
Recommendation Remarks
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNA
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentGrants Review CommentNA
Number Of Recommendations*308Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentSince FY2007, the committee has approved a total of 308 individual recommendations contained within 27 sets of recommendations. These recommendations are developed through extensive subject-matter input from the NVAC working groups, as well as extensive deliberations by the full committee. The focus of these recommendations have included: vaccine safety; pandemic H1N1 vaccine; vaccine financing of childhood and adolescent vaccinations; establishing a platform for adult immunizations; strengthening immunization information systems; supporting immunization infrastructure; improving influenza vaccination uptake in healthcare personnel; reviewing HHS efforts to support global immunization activities; overcoming patient and provider barriers to uptake of recommended vaccines in pregnant women; promoting research and development of vaccines for use in pregnant women; improving uptake of HPV vaccination in adolescents; strategies to measure, evaluate, and promote vaccine confidence and acceptance in the U.S; and the role of vaccines in national strategies to combat antibiotic resistant bacteria. In FY 2019, the NVAC approved five individual recommendations related to the development of the 2020 National Vaccine Plan.Access Agency WebsiteYes
% of Recs Fully Implemented*34.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentAccess GSA FACA WebsiteYes
% of Recs Partially Implemented*49.00%Access PublicationsYes
% of Recs Partially Implemented CommentSome recommendations have not been fully implemented due to resource limitations or remain as works in progress. Additionally, because many of the recommendations are complex, only portions have been implemented.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*The Assistant Secretary for Health (ASH) functions as the Director of the National Vaccine Program. In this capacity, the ASH provides guidance and direction to the National Vaccine Program in the Office of Infectious Disease and HIV/AIDS Policy (OIDP). OIDP provides staffing support to the committee and has been tasked with tracking the progress of approved recommendations. The status of Departmental efforts to implement NVAC recommendations is reported back to the committee during their scheduled meetings.Narrative Description*The National Vaccine Advisory Committee (NVAC) was established in 1987 to comply with Title XXI of the Public Health Service Act (P.L. 99-660) (Section 2105) (42 U.S. Code 300aa-5). The NVAC serves an advisory role, providing peer review, consultation, advice, and recommendations to the Assistant Secretary for Health in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States; recommends research priorities and other measures to enhance the safety and efficacy of vaccines. The committee also advises the Assistant Secretary for Health in the implementation of the National Vaccine Plan.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$6,750.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$31,354.00Est. Payments to Fed Members Next FY*$32,000.00
Payments to Federal Staff*$261,475.25Estimated Payments to Federal Staff*$318,274.00
Payments to Consultants*$29,250.00Est. Payments to Consultants Next FY*$37,813.00
Travel Reimb. For Non-Federal Members*$39,060.83Est Travel Reimb Non-Fed Members nextFY*$39,530.00
Travel Reimb. For Federal Members*$4,300.00Est Travel Reimb For Fed Members*$4,000.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$85,000.00Est. Other Costs Next FY*$88,000.00
Total Costs$457,190.08Est. Total Next FY*$519,617.00
Federal Staff Support (FTE)*2.00Est. Fed Staff Support Next FY*2.50
Hide Section - Interest Areas

Interest Areas

Category
Area
Applied Science
Applied Sciences
Statistics
Basic Science
Basic Sciences
Business
Industry
Manufacturing
Civil Rights
Children
Minorities
Native Americans
Women
Computer Technology
Technology
Data
Data Integrity
Data Quality
Education
Education
Emergency
Emergency Preparedness and Management
Food and Drugs
Biotechnology
Food and Drugs
Government
Federal Government
Health
Health Care
Hospitals
Medical Education
Medical Practitioners
Public Health
Safety
Aging
Justice
Research and Statistics
Labor
Occupational Safety and Health
Workforce and Occupations
Legislation
Regulations
Medicine
Diseases
Health and Health Research
Illnesses
Medicine and Dentistry
National Defense
National Security and Defense
Overseas Security Issues
Research
Basic Research
Research and Development
Research and Statistics
Science and Technology
Innovation
Science and Technology
Social Sciences
Risk Communication
Social Sciences
Veterans
Veterans and Veterans' Medical Care
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - SUBCOMMITTEES

SUBCOMMITTEES

Committee

Subcommittees

ActionCommittee System IDSubcommittee NameFiscal Year
 COM-035020Equity in Immunization Subcommittee2019
 COM-032797National Vaccine Plan Working Group2019
 COM-035021Vaccine Confidence Subcommittee2019
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-034917National Vaccine Advisory Committee2018
 COM-001948National Vaccine Advisory Committee2017
 COM-002399National Vaccine Advisory Committee2016
 COM-003766National Vaccine Advisory Committee2015
 COM-004420National Vaccine Advisory Committee2014
 COM-006158National Vaccine Advisory Committee2013
 COM-006902National Vaccine Advisory Committee2012
 COM-008285National Vaccine Advisory Committee2011
 COM-009039National Vaccine Advisory Committee2010
 COM-010081National Vaccine Advisory Committee2009
 COM-010972National Vaccine Advisory Committee2008
 COM-012215National Vaccine Advisory Committee2007
 COM-012558National Vaccine Advisory Committee2006
 COM-014049National Vaccine Advisory Committee2005
 COM-014453National Vaccine Advisory Committee2004
 COM-015854National Vaccine Advisory Committee2003
 COM-016789National Vaccine Advisory Committee2002
 COM-017701National Vaccine Advisory Committee2001
 COM-018467National Vaccine Advisory Committee2000
 COM-019720National Vaccine Advisory Committee1999
 COM-020508National Vaccine Advisory Committee1998
 COM-021664National Vaccine Advisory Committee1997